Baerveldt glaucoma implant with Supramid© ripcord stent in neovascular glaucoma: a case series
AIM: To report the outcome of Baerveldt glaucoma implant (BGI) with Supramid© ripcord use in neovascular glaucoma (NVG). METHODS: We retrospectively evaluated the surgical outcome of the BGI with Supramid© 3/0 ripcord stent in patients with NVG. No tube ligation or venting slits were performed. Supr...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2024-02-01
|
| Series: | International Journal of Ophthalmology |
| Subjects: | |
| Online Access: | http://ies.ijo.cn/en_publish/2024/2/20240206.pdf |
| _version_ | 1797348645073321984 |
|---|---|
| author | Yuen Keat Gan Shiivaa Manjare Birapadian Muhammad Irfan Abdul Jalal Norshamsiah Md Din |
| author_facet | Yuen Keat Gan Shiivaa Manjare Birapadian Muhammad Irfan Abdul Jalal Norshamsiah Md Din |
| author_sort | Yuen Keat Gan |
| collection | DOAJ |
| description | AIM: To report the outcome of Baerveldt glaucoma implant (BGI) with Supramid© ripcord use in neovascular glaucoma (NVG). METHODS: We retrospectively evaluated the surgical outcome of the BGI with Supramid© 3/0 ripcord stent in patients with NVG. No tube ligation or venting slits were performed. Supramid was removed after 3mo if the target intraocular pressure (IOP) was not achieved. Surgical success was defined as IOP≤21 mm Hg with (qualified success) or without IOP-lowering medications (complete success). RESULTS: Twenty-six eyes from 24 patients were included in the study. The median duration of follow-up was 4 [interquartile range (IQR)=1-5]y, ranging from 0.5 to 5y. IOP decreased by a mean of 24.2 mm Hg (59.7%); from a mean of 40.5±12.6 mm Hg at baseline to 16.3±11.9 mm Hg, P≤0.001. The number of glaucoma medications reduced from a median of 5 (IQR=5-6) to 1 (IQR=0-2, P≤0.001) at the final follow-up. Overall success rates were 88.0% at 1y, 34.8% at 3y, 66.7% at 4y, and 50% at 5y. Hypertensive phase (HP) in the first 3mo occurred in 15/26 eyes (57.7%) with a mean IOP of 31.1 mm Hg. CONCLUSION: BGI with Supramid© ripcord stent gives close to 90% of the overall survival rate at the final follow-up without significant early hypotony. However, early HP is still a challenge. |
| first_indexed | 2024-03-08T12:08:50Z |
| format | Article |
| id | doaj.art-8d5258d47ab646f6aa7b483e80d80e70 |
| institution | Directory Open Access Journal |
| issn | 2222-3959 2227-4898 |
| language | English |
| last_indexed | 2024-03-08T12:08:50Z |
| publishDate | 2024-02-01 |
| publisher | Press of International Journal of Ophthalmology (IJO PRESS) |
| record_format | Article |
| series | International Journal of Ophthalmology |
| spelling | doaj.art-8d5258d47ab646f6aa7b483e80d80e702024-01-23T03:42:33ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982024-02-0117226527110.18240/ijo.2024.02.0620240206Baerveldt glaucoma implant with Supramid© ripcord stent in neovascular glaucoma: a case seriesYuen Keat Gan0Shiivaa Manjare Birapadian1Muhammad Irfan Abdul Jalal2Norshamsiah Md Din3Norshamsiah Md Din. Department of Ophthalmology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia. shamsiahdr@hotmail.comDepartment of Ophthalmology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, MalaysiaUKM Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, MalaysiaDepartment of Ophthalmology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia; Hospital Canselor Tuanku Muhriz, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur 56000, MalaysiaAIM: To report the outcome of Baerveldt glaucoma implant (BGI) with Supramid© ripcord use in neovascular glaucoma (NVG). METHODS: We retrospectively evaluated the surgical outcome of the BGI with Supramid© 3/0 ripcord stent in patients with NVG. No tube ligation or venting slits were performed. Supramid was removed after 3mo if the target intraocular pressure (IOP) was not achieved. Surgical success was defined as IOP≤21 mm Hg with (qualified success) or without IOP-lowering medications (complete success). RESULTS: Twenty-six eyes from 24 patients were included in the study. The median duration of follow-up was 4 [interquartile range (IQR)=1-5]y, ranging from 0.5 to 5y. IOP decreased by a mean of 24.2 mm Hg (59.7%); from a mean of 40.5±12.6 mm Hg at baseline to 16.3±11.9 mm Hg, P≤0.001. The number of glaucoma medications reduced from a median of 5 (IQR=5-6) to 1 (IQR=0-2, P≤0.001) at the final follow-up. Overall success rates were 88.0% at 1y, 34.8% at 3y, 66.7% at 4y, and 50% at 5y. Hypertensive phase (HP) in the first 3mo occurred in 15/26 eyes (57.7%) with a mean IOP of 31.1 mm Hg. CONCLUSION: BGI with Supramid© ripcord stent gives close to 90% of the overall survival rate at the final follow-up without significant early hypotony. However, early HP is still a challenge.http://ies.ijo.cn/en_publish/2024/2/20240206.pdfneovascular glaucomasupramid ripcord stentbaerveldt glaucoma implant |
| spellingShingle | Yuen Keat Gan Shiivaa Manjare Birapadian Muhammad Irfan Abdul Jalal Norshamsiah Md Din Baerveldt glaucoma implant with Supramid© ripcord stent in neovascular glaucoma: a case series International Journal of Ophthalmology neovascular glaucoma supramid ripcord stent baerveldt glaucoma implant |
| title | Baerveldt glaucoma implant with Supramid© ripcord stent in neovascular glaucoma: a case series |
| title_full | Baerveldt glaucoma implant with Supramid© ripcord stent in neovascular glaucoma: a case series |
| title_fullStr | Baerveldt glaucoma implant with Supramid© ripcord stent in neovascular glaucoma: a case series |
| title_full_unstemmed | Baerveldt glaucoma implant with Supramid© ripcord stent in neovascular glaucoma: a case series |
| title_short | Baerveldt glaucoma implant with Supramid© ripcord stent in neovascular glaucoma: a case series |
| title_sort | baerveldt glaucoma implant with supramid c ripcord stent in neovascular glaucoma a case series |
| topic | neovascular glaucoma supramid ripcord stent baerveldt glaucoma implant |
| url | http://ies.ijo.cn/en_publish/2024/2/20240206.pdf |
| work_keys_str_mv | AT yuenkeatgan baerveldtglaucomaimplantwithsupramidripcordstentinneovascularglaucomaacaseseries AT shiivaamanjarebirapadian baerveldtglaucomaimplantwithsupramidripcordstentinneovascularglaucomaacaseseries AT muhammadirfanabduljalal baerveldtglaucomaimplantwithsupramidripcordstentinneovascularglaucomaacaseseries AT norshamsiahmddin baerveldtglaucomaimplantwithsupramidripcordstentinneovascularglaucomaacaseseries |